At Nett Pharmacy, we prioritize authentic, NAFDAC-registered medications
The following is a summary of Evaluating the causal relationship of Levo-carnitine and risk of schizophrenia: a bidirectional two-sample mendelian randomization study, published in the October 2024 issue of Psychiatry by Qiu et al
[14] Saha, U., Gupta, P., & Singh, M
Laboratory studies in animals indicate that GLP-1 RAs target hallmarks of brain aging and may activate neuroprotective pathways that promote cellular waste removal, reduce neuroinflammation, promote mitochondrial health and regeneration which may alleviate symptoms of cognitive decline in models of Parkinsons and Alzheimers diseases
Patients currently using compounded semaglutide or tirzepatide should discuss transitioning to FDA approved formulations with their healthcare provider